1. Home
  2. SIBN

as 05-30-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Founded: 2008 Country:
United States
United States
Employees: N/A City: SANTA CLARA
Market Cap: 571.0M IPO Year: 2018
Target Price: $24.40 AVG Volume (30 days): 604.0K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.63 EPS Growth: N/A
52 Week Low/High: $11.70 - $20.05 Next Earning Date: 05-05-2025
Revenue: $176,601,000 Revenue Growth: 22.60%
Revenue Growth (this year): 19.3% Revenue Growth (next year): 15.28%

SIBN Daily Stock ML Predictions

Stock Insider Trading Activity of SI-BONE Inc. (SIBN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Maheshwari Anshul SIBN Chief Financial Officer May 16 '25 Sell $19.67 12,009 $236,611.68 224,507
Maheshwari Anshul SIBN Chief Financial Officer May 7 '25 Sell $17.59 33,287 $599,033.35 224,507
FRANCIS LAURA SIBN Chief Executive Officer May 7 '25 Sell $17.18 38,504 $661,367.81 302,958
DUNN JEFFREY W SIBN Director May 1 '25 Sell $13.78 336 $4,628.40 12,536
RECUPERO ANTHONY J SIBN President, Commercial Ops Apr 2 '25 Sell $14.15 3,311 $46,852.55 284,555
Maheshwari Anshul SIBN Chief Financial Officer Apr 2 '25 Sell $14.11 3,311 $46,723.49 224,507
Pisetsky Michael A SIBN SVP, Ops & Adm/Chief Legal Ofr Apr 2 '25 Sell $14.04 3,128 $44,219.05 244,878

Share on Social Networks: